Johnson and Johnson Pharmacy

FDA approves Johnson & Johnson’s nasal spray for depression

FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

CNN · 1d

FDA approves standalone use of J&J’s ketamine-derived depression treatment

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

Business Insider · 2d

JNJ's SNDA For Spravato Monotherapy Gets FDA Approval For Treatment-Resistant Depression

Tuesday announced that the U.S. Food and Drug Administration has approved supplemental New Drug Application or sNDA for Spravato, a monotherapy for adults with treatment-resistant depression, a psychiatric disorder.

Forbes1y

Johnson And Johnson Stock Slips After Missing The Mark For Earnings

Johnson and Johnson revealed lower earnings and sales numbers than expected in Q4 2022 Even before Q4 numbers were released, JNJ started falling after a slew of new stories hit the press Even ...

Hosted on MSN1mon

Johnson & Johnson sues Cigna units for alleging draining funds intended for copays: report

Johnson & Johnson (NYSE ... According to the report, J&J added Cigna’s Express Scripts pharmacy benefits manager and specialty pharmacy Accredo as defendants in an amended lawsuit it filed ...

Business Insider28d

Johnson & Johnson licensing STAT6 program from Kaken Pharmaceutical

Johnson & Johnson announced that it has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic ...

Fortune2y

Johnson & Johnson

Johnson & Johnson, founded in 1886, makes and sells medical devices, pharmaceuticals, and consumer health products. Headquartered in New Brunswick, N.J., the company operates over 250 subsidiary ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results